VIVEbiotech
Chemicals & Related Products · Spain · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Miramon Pasealekua 170 Fl 1, Donostia-Sa...Phone Number
+34 943308568Website
www.vivebiotech.comRevenue
$29.6 MillionIndustry
About VIVEbiotech
Is VIVEbiotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if VIVEbiotech is spiking on competitors!
Earning: See what the market has to say on VIVEbiotech recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
VIVEbiotech, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at VIVEbiotech
Click to see if VIVEbiotech had a recent Job posting/layoffs
Check if VIVEbiotech has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when VIVEbiotech launches new products
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once VIVEbiotech has new funding data
Recommended Actions
Find VP level buyers at VIVEbiotech
Find 3 more new buyers
Company Profile Activity
Activity Insights
VIVEbiotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
VIVEbiotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about VIVEbiotech.
VIVEbiotech Tech Stack
A closer look at the technologies used by VIVEbiotech
Most Recent Scoops
VIVEbiotech News & Media
VIVEbiotech Receives Investment from Ampersand Capital Partners
VIVEbiotech, a San Sebastian, Spain-based lentiviral vector contract development and manufacturing organization (CDMO), received a growth equity investment from Ampersand Capital Partners. The amount of the deal was not disclosed. As part of the transaction, industry veteran Dr. Stefan Beyer has been named Chairman of VIVEbiotech. The company intends to use the funds to enable […] The post VIVEbiotech Receives Investment from Ampersand Capital Partners appeared first on FinSMEs.VIVEbiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities
SAN SEBASTIAN, Spain, Dec. 4, 2024 /PRNewswire/ -- VIVEbiotech, a leading lentiviral vector Contract Development and Manufacturing Organization (CDMO), today announced a growth equity investment from Ampersand Capital Partners ("Ampersand"), a private equity firm specializing in the life...
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VIVEbiotech
VIVEbiotech is a Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of GMP lentiviral vectors for both ex-vivo and in-vivo applications. With over 10 years of experience and a team of professionals, the company offers tailored solutions to meet the specific requirements of its clients, which... Read More